Skip to content
Summer 2026 · 26% off every plan with SUMMER26 See pricing
Optionomics
SEM · 10-Q filed April 30, 2026

SEM earnings analysis

What we found in SEM's 10-Q: the parts that mattered, the offsets in the same document, and what the company said about what comes next.

Our reading of the filing · Free to read, no account needed

In Q1 2026, Select Medical Holdings Corporation reported revenue of $1.42 billion, a 5.0% increase from $1.35 billion in Q1 2025. Gross margin declined slightly to 10.3%, while diluted EPS decreased to $0.44 from $0.43 year-over-year. The Rehabilitation Hospital segment demonstrated robust growth, with a 14.5% rise in revenue, while the Critical Illness Recovery Hospital segment remained flat. Management anticipates that ongoing labor costs and regulatory changes will impact future financial performance.

What stood out

The parts that mattered.

Pulled out of the filing itself, with the figures the company reported.

Revenue Growth Continues
Q1 2026 revenue increased by 5.0% to $1.42 billion from $1.35 billion in Q1 2025.
Operating Income Declines
Operating income fell to $98.4 million, a decrease of 12.7% from $112.7 million a year prior.
Rehabilitation Hospital Segment Outpaces Others
Rehabilitation hospital revenue surged 14.5% to $351.9 million compared to $307.4 million in Q1 2025.
Adjusted EBITDA Decline
Adjusted EBITDA decreased 6.5% to $141.6 million from $151.4 million year-over-year.
Strong Operating Cash Flow Improvement
Operating cash flow improved to $37.9 million in Q1 2026 from cash used of $3.5 million in Q1 2025.
Work Capital Growth
Net working capital increased significantly to $141.7 million from $40.8 million at year-end 2025.
What to watch

And the other side of it.

The offsets in the same document — the things a summary that only listed the good news would have left out.

Labor Cost Increases
Management noted ongoing inflationary pressures, especially in labor costs, impacting margins.
Regulatory Risks
Changes in Medicare reimbursement policies may adversely affect revenue and profitability.
Merger Risks
Pending litigation related to the proposed merger could delay or prevent its completion, impacting business operations.
The numbers

What they reported.

What the company itself reported, taken out of the document.

What survived to operating profit
Of every $100 of revenue Cost of sales $90 Operating expenses $3 Left as operating profit $7
Percentages of revenue, taken from the filing. Drawn this way because it holds whatever scale the company reports in.
Earnings per share
$0.44
Gross margin
10.3%
Operating margin
6.9%
Segment
Critical Illness Recovery Hospital: $638.8M
Segment
Rehabilitation Hospital: $351.9M
Segment
Outpatient Rehabilitation: $321.3M
Guidance

What they said about what is next.

Management notes potential challenges from regulatory changes and increasing labor costs.

How we read the filing overall

The filing reads about the same as the one before it.

One reading of one document. It is not advice, and it is not a forecast.

This is our reading of a public filing, not the filing. Read the original on SEC.gov · Educational only. Nothing here is investment advice.

Read the next one first.

We read every filing SEM makes the day it lands, and put it next to what the options market did about it. Members get both, and an alert when a filing arrives.

Cancel anytime · Month to month · Switch tiers whenever